This is how I read it.
The key to getting the potency assay validated is a successful randomized controlled clinical trial in adults with biomarker evidence that correlates with the Mechanism of Action and the potency assay. Investors here don't seem to have grasped the concept that that is how the FDA will agree the potency assay has been properly "validated" instead of "improved".
SI is still resisting the idea of doing a randomized and properly controlled clinical trial probably because he's afraid it could fail to show efficay which would completely doom Remestemcel and the company. So he has once again proposed a single arm trial that he thinks stacks the odds more favourably and the FDA have given a luke warm response that they will "consider it" at another meeting. But clearly it's not what they want. What they want to see is the whole box and dice sorted out in one properly designed and executed trial.
- Forums
- ASX - By Stock
- Ann: Mesoblast Type A Meeting with FDA
This is how I read it. The key to getting the potency assay...
-
- There are more pages in this discussion • 541 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 103162 | 0.970 |
5 | 34741 | 0.965 |
11 | 125566 | 0.960 |
1 | 500 | 0.955 |
22 | 165429 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.990 | 10204 | 1 |
1.000 | 14000 | 1 |
1.010 | 2877 | 1 |
1.015 | 60000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
MSB (ASX) Chart |